New approaches to the treatment of acute respiratory tract infections in children with frequent acute respiratory diseases (results of multicentre trial according to CHIBIS program)
Samsygina, G.A.; Fitilev, S.B.; Levin, A.M.
Pediatriya (Moscow) (1): 37-38,40-46
Open comparative multicenter trial of Bioparox clinical efficacy in therapy of acute respiratory tract infections (ARTI) in children with frequent acute diseases (ChFAD), performed in 42 scientific centers of 37 Russian regions in period October 2004 - February 2005 included 2609 patients. Authors showed that Bioparox usage (in main group) permitted to receive complete recovery within 10 days in 88.1% of cases in comparison with 68.8% in control group treated by standard therapy.